U.S. Customs seizes 102,000 banned pills in Cincinnati
The pills were shipped by the same entity in Mexico and were destined for the same residence in California, CBP officials said Tuesday in a news release.
The customs declaration for six packages containing the pills describes them as "Nutritional Supplement Natural INGR," according to the CBP.
"Most people hear about CBP seizing narcotics shipments," CBP Chicago Field Office director of operations LaFonda Sutton-Burke said. "Shipments of unapproved pills are very dangerous, too."
Sutton-Burke said the U.S. Food and Drug Administration has not approved the potentially dangerous pills.
The pills "contain harmful chemicals which can lead to medical emergencies or even death," Simon-Burke said.
The Artri King pills are promoted as treatment for muscle pain, arthritis, osteoporosis, bone cancer and other conditions and are sold through some retail stores and websites, such as Amazon.com, Walmart.com and latinfoodsmarket.com.
FDA lab analyses show the pills contain undeclared ingredients and are associated with liver toxicity and deaths.
The FDA in April 2022 issued a warning saying the pills contain diclofenac and dexamethasone, neither of which are listed among its ingredients.
"Consumers taking Artri King should immediately consult with their health care professional to safely discontinue use of this product," the FDA warning says.
Dexamethasone is a corticosteroid that FDA officials say commonly is used to treat inflammatory conditions.
Corticosteroids can impair a person's ability to fight infections and could cause high blood sugar levels, muscle injuries and psychiatric problems, according to the FDA.
When taken over an extended periods or in high doses, they can suppress the adrenal gland, cause withdrawal symptoms and cause serious side effects when combined with other medications.
Diclofenac is a non-steroidal and anti-inflammatory drug commonly referred to as "NSAIDs" that could increase users' risks of heart attack, stroke and other cardiovascular medical events.
The drug also could cause serious gastrointestinal damage, including bleeding, ulcers and fatal perforations of the stomach and intestines.
It also might interact with other medications and significantly increase the risk of harmful medical reactions.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
NBC News
a minute ago
- NBC News
Sunscreen mousse may be dangerous — here's what you need to know
Wearing sunscreen is non-negotiable. Experts have told us over and over that applying it daily can lower your risk of developing skin cancer and prevent early signs of aging. And while there are some rules around the type of sunscreens that are best — like you should opt for a SPF 30 or higher — other things are generally thought to be dependent on personal preference. For example, some people may prefer a mineral option, while others like a chemical sunscreen. Formula consistency is another thing that has always been thought to be up to preference — silky serum, creamy lotion, whatever. But the US Food and Drug Administration just issued warnings to several popular sunscreen brands, suggesting that there is one type of sunscreen that is better left on the shelf. These brands all sell trendy mousse sunscreens (also called whipped sunscreen), and the FDA says this specific type of formulation may not be safe. Below, everything you need to know about this warning. Why is the FDA issuing warnings about mousse sunscreen? Whipped sunscreens from brands like Supergoop! and Vacation Inc. have been one of the trendier beauty products of the summer. But the FDA is letting consumers know that they should proceed with caution. On August 12, they posted a message on X that said, 'Beware of sunscreen products in mousse form because they might not be effective. The FDA issued five warning letters to companies marketing sunscreen products in mousse form.' The FDA explained that regulations allow brands to market sunscreens as creams, lotions, sticks, sprays and a few other formulations — but they do not allow for mousse or whipped formulations. They also said that certain companies have created bottles that look like cans of whipped cream, which can put consumers at risk if ingested. The brands that received warning letters are Supergoop!, Vacation Inc., Kalani Sunwear, Fallian Cosmeceuticals (TiZo brand) and K & Care Organics. These letters don't necessarily mean the mousse sunscreens produced by these brands are unsafe. The FDA just requires that any new form is required to have sufficient data proving they are safe and effective — and those things haven't been submitted. The brands have 15 working days to respond. If they fail to comply, it is possible that the products could be pulled from the market. The coming weeks will be very telling when it comes to mousse sunscreens and whether or not these companies address the concerns raised by the FDA. Until then, it may be a smarter move to stick to formulations not under attack by the FDA. Below, a few sunscreen options that have been recommended to us previously by experts or NBC Select staffers. A favorite amongst NBC Select staffers, this sunscreen has an SPF 46 and is specifically made for the face. The oil-free formula utilizes zinc oxide as its main ingredient to physically block UVA and UVB rays. The formula is lightweight and good for those with sensitive skin, according to the brand. Just because the mousse sunscreen from Supergoop was issued a warning, it doesn't mean all of the brand's products are off limits. This gel formula is another favorite of staffers. 'It has a smooth, almost silky feel to it that my skin absorbs quickly, giving the same finish as some of my high-end makeup primers,' says NBC Select associate reporter Ashley Morris. The go-to sunscreen in my house, I love that I can quickly spray my kids down with SPF as we head out the door. It also absorbs quickly and has a pleasant coconut scent. Along with ingredients that protect your skin, this formula contains vitamin E to keep skin moisturized, according to the brand. Why trust NBC Select? Bethany Heitman is a contributor at NBC Select and a journalist who regularly covers topics like beauty, home and lifestyle and debunks popular skin care trends and online fads.
Yahoo
7 minutes ago
- Yahoo
Apple Watch update will include blood oxygen feature
Aug. 14 (UPI) -- Apple will roll out an update to the Apple Watch on Thursday to add its new pulse oximeter feature that has been stalled because of an intellectual property dispute. Apple said in a press release that it will update Apple Watch Series 9, Series 10 and the Apple Watch Ultra 2. These models will get the redesigned Blood Oxygen feature. "Apple's teams work tirelessly to create products and services that empower users with industry-leading health, wellness, and safety features that are grounded in science and have privacy at the core," Apple said in a statement. "Apple Watch Series 9, Series 10, and Apple Watch Ultra 2 also offer users irregular rhythm notifications, the ECG app, Sleep Apnea Notifications, Fall Detection, sleep tracking, wrist temperature sensing, the Vitals app, the Noise app, the Medications app, and the Mindfulness app, among many other helpful tools, helping users live a healthier life." The International Trade Commission in October 2023 ruled in favor of a request to halt sales of the Apple smartwatches by medical technology firm Masimo Corp. Masimo officials say Apple co-opted its patented technology and poached several workers who helped to develop it. Apple then paused the sale of some of its watches and began selling modified versions of them without the blood-oxygen feature. The update is possible thanks to a recent U.S. Customs ruling, the company said. There will be no effect to Apple Watch units previously purchased that include the original Blood Oxygen feature or to Apple Watch units purchased outside of the U.S., Apple said.
Bloomberg
33 minutes ago
- Bloomberg
WHOOP CEO Says Its Blood Pressure Tool ‘Follows the Law'
00:00 What's your view that the FDA does not have authority in this moment, your wellness, not medical device? Well, thanks for having me on. You know, you've spent the last three years developing a very innovative feature called Blood Pressure Insights, and this takes our wrist worn wearable alongside a calibration with a cuff and is allowed to provide you with a daily estimate of your blood pressure. And in turn, it also then gives you insights how your blood pressure may be affecting other things in your wellness. This could be sleep, stress, nutrition, a variety of different wellness factors. And the FDA is coming forward saying that they believe that this should be regulated. Now, the 21st Century Cures Act makes it very clear that wellness intended features are not supposed to be regulated by the FDA, and the FDA is intended to actually just regulate medical devices that are diagnosing something. So there's this key question of intended use. And you can see this with other physiological metrics like heart rate monitoring, for example, where Hari monitoring has wellness applications and medical applications. The wellness applications might be things like exercise or stress monitoring or sleep monitoring. And we do all that right. And alternatively, there could be, you know, a diagnosis for AFib, and that would be an example where the say, well, well, that's what the FDA misinterpreted of. Right. But you're a smart guy and you employ lots of smart people. Why not just go through the FDA process in the first place kind of foreseeing that this might come up? Well, you have to understand, there's different use cases, right? One use case for blood pressure is around wellness. And there's other use cases that might be a medical diagnosis. And we're certainly looking at, you know, cleared products as well and a longer term horizon. But we're providing a lot of value today and we're following the law again. The 21st Century Cures Act makes it very clear if a product is intended for a wellness use case, it's not supposed to be regulated by the FDA. So then the fundamental question becomes, does blood pressure have wellness intended use cases? We believe it does, right? There's an avalanche of peer reviewed research that shows that blood pressure, not surprisingly, is influenced and influences other aspects of your well, well, why call it medical grade? Why market it that way? Well, we recently came out with the WOOP five data and the BMJ and a key distinguishing factor between the five data and the M.G. is that the M.G. has a medically cleared feature on it. Now, both of those products have a number of wellness features associated with it. The WU PMG happens to have an EKG monitor as part of that that can detect A-fib. And by the way, we spent two and a half years working with the FDA to have that be a cleared feature. So that is the distinguishing factor between those two hardware's. And I want to be very clear in the app, there's an enormous number of medical disclaimers explaining what is for wellness and what is for medical capabilities. Well, you've said this is a misunderstanding. What happens next? Will you continue to fight the FDA on or in the background? Are you trying to reach some solution? We have a lot of respect for the team and we've engaged with them on a number of different features over the years. We think in this specific case they have it wrong and so we're going to continue engaging with them on it. We've responded to their warning letter outlining how we feel about this and why we think we're following the law and we look forward to continuing to engage with them on it. Well, that must take up head space and ultimately your time. How does that impact your future product roadmap? How does more broadly, the FDA acting this way affect innovation more broadly, do you think? Ultimately, I think that, you know, innovation needs to be able to thrive in the United States. WOOP is one of the first wearables in the world that can measure blood pressure accurately from the wrist. That's a really big deal. And it's also being accepted in 50 other markets around the world. So, you know, we want to make sure that there's policies that are consistent here in the U.S. that really allow companies to innovate and to operate. It's also worth noting, you know, we have a lot of people using this every single day. And overwhelmingly, if you look at the feedback from our members, they absolutely love this feature and they talk about how accurate is and how it's helping them understand their wellness. So we feel like we're on the right side of history and we're going to continue educating the FDA on what we're doing. Well well, I'm very quickly I'm not a we use it, but I'm very conscious that in the Premier League and other international football players, it's it's very in the public conscience. I just wonder like is this a good PR moment for you to fight America's regulator? I think in the long run will be on the right side of history and that maybe in a very short period of time, too. I think that fighting for innovation, fighting for Americans access to health data is the right thing to do. And, you know, I've spent 13 years building this company. When I first started, the idea that you could measure sleep or heart rate accurately from the wrist seemed impossible. And now we're able to do blood pressure accurately from the wrist. That's a really big deal. And I think it should be celebrated as long as there's the right guidelines in place and the right education in place for members to understand how to use. And that's what we've done with this feature, and that's why we're proud of it.
